About
MHI is proud to present the Global H2 Health Summit. For the first time in hydrogen history, MHI bridges the academic research symposium with a general hydrogen conference for the public in this virtual Global H2 Health Summit. This provides a platform for leading researchers to share their work with other hydrogen experts and enthusiasts alike. With over 2000 scientific articles (and 140+ human studies) published on hydrogen, the therapeutic potential is both promising and exciting. However, there is still a lot we don’t know, which is why the Global H2 Health Summit is so important.
Not only will researchers share their latest cutting-edge research with other academics and the general public. Come learn more about this tiny molecule at the first-ever Global H2 Health Summit! Your participation is a valuable contribution to supporting the advancement of this research.
Researcher / Academic Symposium
If you are a researcher, this is your opportunity to share your research with your colleagues and other academic researchers. There will be many hydrogen researchers, as well as other academics who are interested in hydrogen research. This is a great way to publicize your research, increase your citations, and form collaborations to advance the hydrogen research. We invite you to submit an abstract for an online video or poster presentation. Every abstract will be reviewed and if accepted, you can submit several presentations for either the academic researchers, as well as the general consumer.
General Public / Hydrogen Health Conference
Whether you are a researcher, health physician, medical student, salesperson, a health-conscious consumer, or a salesperson, this virtual conference is a once-in-a-lifetime opportunity to hear from the actual researchers and meet the true experts. For the first time in hydrogen history, we are opening the academic symposium to the general public and making a concerted effort to present the science to the general public.
Meet your Conference Chairs!
Welcome!
This is the first-ever Global H2 Health Summit! This is the first time the hydrogen industry has ever seen a virtual conference that merges the general public with academia.
Please join us as top-tier researchers across the world present their findings on hydrogen and health.
Thank you,
Dr. Tyler W. LeBaron, Chair & Dr. John Kheir, Co-Chair
Dr. Tyler W. LeBaron, MSc., PhD.
Executive Director,
Molecular Hydrogen Institute
Adjunct Professor,
Southern Utah University
Dr. John Kheir, MD.
Associate Professor of Pediatrics,
Harvard Medical School
Staff Physician,
Boston Children’s Hospital
About MHI
Molecular Hydrogen Institute (MHI) is a 501(c)3 tax-exempt, science-based nonprofit. This conference will further the mission of MHI which is to provide education on, advance research about, and promote awareness of molecular hydrogen’s therapeutic potential.
MHI is the foremost authority on the science of molecular hydrogen, and has four main objectives:
A Message from MHI Founder
Since 2009, I have been interested in the potential therapeutic effects of molecular hydrogen. At the time there were only around 20 scientific articles on this area, compared to over 100 times as many today. It has been a great pleasure to watch and participate in this exciting development. I feel very grateful to have gotten to know and collaborate with many of these internationally recognized researchers.
When I founded the Molecular Hydrogen Institute (MHI) in 2013 following my internship in Japan at Nagoya University, I didn’t expect that 11 years later MHI would unite research scientists worldwide with the general public for this virtual Global Health H2 summit. This is a unique summit where the public can attend the lectures of the academic hydrogen symposium, and where academic researchers will also give presentations for the general H2 health conference tailored to the public. This summit is a convergence of academic rigor and accessibility, marking a pivotal moment in the trajectory of molecular hydrogen research.
Tyler W. LeBaron, MSc., PhD.
Supported by IJMS
